Bill > S0876

This bill requires health insurers and health maintenance organizations (HMOs) in Florida to ensure fair access to Chimeric Antigen Receptor T-cell (CAR-T) therapy, a cutting-edge cancer treatment. Specifically, if an insurance policy or health maintenance contract provides coverage for CAR-T therapy starting January 1, 2026, the insurer cannot refuse to contract with or deny coverage for a provider that is certified by the Food and Drug Administration (FDA) for CAR-T therapy and is already included in the policy's provider network for other services. This legislation applies to individual health insurance policies, group health insurance policies, and HMO contracts, ensuring that patients have consistent access to this advanced medical treatment across different types of health plans. The bill aims to prevent insurers from arbitrarily excluding qualified CAR-T therapy providers, thus potentially improving patient access to this specialized cancer treatment.